...
首页> 外文期刊>The journal of technology transfer >Technology transfer perspectives in globalising India (drugs and pharmaceuticals and biotechnology)
【24h】

Technology transfer perspectives in globalising India (drugs and pharmaceuticals and biotechnology)

机译:印度全球化的技术转让观点(药品,制药和生物技术)

获取原文
获取原文并翻译 | 示例
           

摘要

The paper briefly outlines the status of technology transfer related issues in drugs & pharma and biotechnology sectors in India. The paper also outlines the contemporary business strategies including R & D and technology transfer models. The study indicates that present technology transfer policies and mechanisms are weak and need to be restructured. The current fiscal incentives and tax concessions etc. available for R & D in industry seem to have outlived and are no longer attractive because of continuous lowering of tariff rates and tax rates in the context of WTO and liberalization of policies. Moreover, the issue of R & D support to industry is not covered in the WTO as in case of subsidies. Therefore, it is advisable for the government to revisit the existing promotional measures for R & D. FDI policies also need to be tailored to encourage Technology transfers and capability building. Recommendations are made for making Technology Transfer more effective for the growth and competitiveness of the industry. A technology transfer management model is suggested.
机译:本文简要概述了印度药品,制药和生物技术领域与技术转让相关的问题的状况。本文还概述了当代商业战略,包括研发和技术转让模型。研究表明,目前的技术转让政策和机制薄弱,需要重新调整。由于在WTO和政策自由化背景下关税和税率不断降低,目前可用于工业研发的财政激励措施和税收减免等似乎已经过时并且不再具有吸引力。此外,与补贴一样,世贸组织也未涵盖对工业的研发支持问题。因此,建议政府重新考虑现有的研发促进措施。还需要调整外国直接投资政策,以鼓励技术转让和能力建设。提出了一些建议,以使技术转让更有效地促进该行业的增长和竞争力。提出了技术转让管理模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号